Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2

Nucleic Acids Research

Volumn 40, Issue 12, 2012, Pages 5378-5388

  Jayathilaka, Nimanthi ^a   Han, Aidong ^a,d   Gaffney, Kevin J ^a   Dey, Raja ^a   Jarusiewicz, Jamie A ^a   Noridomi, Kaori ^a   Philips, Michael A ^a   Lei, Xiao ^a   He, Ju ^a   Ye, Jun ^a   Gao, Tao ^a   Petasis, Nicos A ^a,b   Chen, Lin ^a,b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING PROTEIN METABOLISM; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BLOCKING AGENT; BML 210; DNA; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 2A; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE INHIBITOR; MYOCYTE ENHANCER FACTOR 2; NAP 1407; NKL 02; NKL 08; NKL 09; NKL 11; NKL 13; NKL 22; NKL 30; NKL 54; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; FLUORINE NUCLEAR MAGNETIC RESONANCE; GENE EXPRESSION REGULATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

ANILIDES; ANIMALS; BINDING SITES; CELL LINE; DNA; HELA CELLS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; MODELS, MOLECULAR; MYOGENIC REGULATORY FACTORS;

EID: 84863194158     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gks189     Document Type: Article

References (45)

1. Paris,M., Porcelloni,M., Binaschi,M. and Fattori,D. (2008) Histone deacetylase inhibitors: from bench to clinic. J. Med. Chem., 51, 1505-1529. (Pubitemid 351438836)
2. Bradner,J.E., West,N., Grachan,M.L., Greenberg,E.F., Haggarty,S.J., Warnow,T. and Mazitschek,R. (2010) Chemical phylogenetics of histone deacetylases. Nat. Chem. Biol., 6, 238-243.
3. Zhang,C.L., McKinsey,T.A., Chang,S., Antos,C.L., Hill,J.A. and Olson,E.N. (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell, 110, 479-488. (Pubitemid 35232291)
4. Tao,R., de Zoeten,E.F., Ozkaynak,E., Chen,C., Wang,L., Porrett,P.M., Li,B., Turka,L.A., Olson,E.N., Greene,M.I. et al. (2007) Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med., 13, 1299-1307. (Pubitemid 350073591)
5. Mottet,D., Bellahcene,A., Pirotte,S., Waltregny,D., Deroanne,C., Lamour,V., Lidereau,R. and Castronovo,V. (2007) Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circ. Res., 101, 1237-1246. (Pubitemid 350294640)
6. Renthal,W., Maze,I., Krishnan,V., Covington,H.E. III, Xiao,G., Kumar,A., Russo,S.J., Graham,A., Tsankova,N., Kippin,T.E. et al. (2007) Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron, 56, 517-529. (Pubitemid 350030878)
7. Tsankova,N.M., Berton,O., Renthal,W., Kumar,A., Neve,R.L. and Nestler,E.J. (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci., 9, 519-525.
8. Bolger,T.A. and Yao,T.P. (2005) Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J. Neurosci., 25, 9544-9553. (Pubitemid 41464769)
9. Bertos,N.R., Wang,A.H. and Yang,X.J. (2001) Class II histone deacetylases: structure, function, and regulation. Biochem. Cell. Biol., 79, 243-252. (Pubitemid 32751917)
10. Verdin,E., Dequiedt,F. and Kasler,H.G. (2003) Class II histone deacetylases: versatile regulators. Trends Genet., 19, 286-293. (Pubitemid 36507011)
11. Clocchiatti,A., Florean,C. and Brancolini,C. (2011) Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis. J. Cell. Mol. Med., 15, 1833-1846.
12. Potthoff,M.J. and Olson,E.N. (2007) MEF2: a central regulator of diverse developmental programs. Development, 134, 4131-4140.
13. Yuki,Y., Imoto,I., Imaizumi,M., Hibi,S., Kaneko,Y., Amagasa,T. and Inazawa,J. (2004) Identification of a novel fusion gene in a pre-B acute lymphoblastic leukemia with t(1;19)(q23;p13). Cancer Sci., 95, 503-507. (Pubitemid 38832699)
14. Prima,V., Gore,L., Caires,A., Boomer,T., Yoshinari,M., Imaizumi,M., Varella-Garcia,M. and Hunger,S.P. (2005) Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K, 19, 806-813.
15. Morin,R.D., Mendez-Lago,M., Mungall,A.J., Goya,R., Mungall,K.L., Corbett,R.D., Johnson,N.A., Severson,T.M., Chiu,R., Field,M. et al. (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature, 476, 298-303.
16. Pasqualucci,L., Dominguez-Sola,D., Chiarenza,A., Fabbri,G., Grunn,A., Trifonov,V., Kasper,L.H., Lerach,S., Tang,H., Ma,J. et al. (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature, 471, 189-195.
17. Lu,J., McKinsey,T.A., Zhang,C.L. and Olson,E.N. (2000) Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol. Cell, 6, 233-244.
18. Wang,A.H. and Yang,X.J. (2001) Histone deacetylase 4 possesses intrinsic nuclear import and export signals. Mol. Cell Biol., 21, 5992-6005. (Pubitemid 32737815)
19. Han,A., He,J., Wu,Y., Liu,J.O. and Chen,L. (2005) Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2. J. Mol. Biol., 345, 91-102. (Pubitemid 39572827)
20. Han,A., Pan,F., Stroud,J.C., Youn,H.D., Liu,J.O. and Chen,L. (2003) Sequence-specific recruitment of transcriptional co-repressor Cabin1 by myocyte enhancer factor-2. Nature, 422, 730-734. (Pubitemid 36514113)
21. Wu,Y., Dey,R., Han,A., Jayathilaka,N., Philips,M., Ye,J. and Chen,L. (2010) Structure of the MADS-box/MEF2 domain of MEF2A bound to DNA and its implication for myocardin recruitment. J. Mol. Biol., 397, 520-533.
22. Papeo,G., Giordano,P., Brasca,M.G., Buzzo,F., Caronni,D., Ciprandi,F., Mongelli,N., Veronesi,M., Vulpetti,A. and Dalvit,C. (2007) Polyfluorinated amino acids for sensitive 19F NMR-based screening and kinetic measurements. J. Am. Chem. Soc., 129, 5665-5672. (Pubitemid 46697656)
23. Santelli,E. and Richmond,T.J. (2000) Crystal structure of MEF2A core bound to DNA at 1.5A resolution. J. Mol. Biol., 297, 437-449.
24. Herman,D., Jenssen,K., Burnett,R., Soragni,E., Perlman,S.L. and Gottesfeld,J.M. (2006) Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia. Nat. Chem. Biol., 2, 551-558. (Pubitemid 44413238)
25. Chen,L., Glover,J.N., Hogan,P.G., Rao,A. and Harrison,S.C. (1998) Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature, 392, 42-48. (Pubitemid 28150581)
26. Wu,Y., Borde,M., Heissmeyer,V., Feuerer,M., Lapan,A.D., Stroud,J.C., Bates,D.L., Guo,L., Han,A., Ziegler,S.F. et al. (2006) FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell, 126, 375-387. (Pubitemid 44092960)
27. Irwin,J.J. and Shoichet,B.K. (2005) ZINC - a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model., 45, 177-182. (Pubitemid 40736970)
28. Wong,J.C., Hong,R. and Schreiber,S.L. (2003) Structural biasing elements for in-cell histone deacetylase paralog selectivity. J. Am. Chem. Soc., 125, 5586-5587. (Pubitemid 36592854)
29. Finnin,M.S., Donigian,J.R., Cohen,A., Richon,V.M., Rifkind,R.A., Marks,P.A., Breslow,R. and Pavletich,N.P. (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature, 401, 188-193. (Pubitemid 29436325)
30. Creemers,E.E., Sutherland,L.B., Oh,J., Barbosa,A.C. and Olson,E.N. (2006) Coactivation of MEF2 by the SAP domain proteins myocardin and MASTR. Mol. Cell, 23, 83-96. (Pubitemid 43963447)
31. Rai,M., Soragni,E., Jenssen,K., Burnett,R., Herman,D., Coppola,G., Geschwind,D.H., Gottesfeld,J.M. and Pandolfo,M. (2008) HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model. PLoS One, 3, e1958.
32. Greene,E., Entezam,A., Kumari,D. and Usdin,K. (2005) Ancient repeated DNA elements and the regulation of the human frataxin promoter. Genomics, 85, 221-230. (Pubitemid 40164787)
33. Li,K., Singh,A., Crooks,D.R., Dai,X., Cong,Z., Pan,L., Ha,D. and Rouault,T.A. (2010) Expression of human frataxin is regulated by transcription factors SRF and TFAP2. PLoS One, 5, e12286.
34. Haggarty,S.J., Koeller,K.M., Wong,J.C., Butcher,R.A. and Schreiber,S.L. (2003) Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. Chem. Biol., 10, 383-396. (Pubitemid 36610312)
35. Hubbert,C., Guardiola,A., Shao,R., Kawaguchi,Y., Ito,A., Nixon,A., Yoshida,M., Wang,X.F. and Yao,T.P. (2002) HDAC6 is a microtubule-associated deacetylase. Nature, 417, 455-458. (Pubitemid 34563539)
36. Haggarty,S.J., Koeller,K.M., Wong,J.C., Grozinger,C.M. and Schreiber,S.L. (2003) Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl Acad. Sci. USA, 100, 4389-4394. (Pubitemid 36457739)
37. Xu,C., Soragni,E., Chou,C.J., Herman,D., Plasterer,H.L., Rusche,J.R. and Gottesfeld,J.M. (2009) Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencing. Chem. Biol., 16, 980-989.
38. He,J., Ye,J., Cai,Y., Riquelme,C., Liu,J.O., Liu,X., Han,A. and Chen,L. (2011) Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly. Nucleic Acids Res., 39, 4464-4474.
39. Mullighan,C.G., Zhang,J., Kasper,L.H., Lerach,S., Payne-Turner,D., Phillips,L.A., Heatley,S.L., Holmfeldt,L., Collins-Underwood,J.R., Ma,J. et al. (2011) CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature, 471, 235-239.
40. Savickiene,J., Borutinskaite,V.V., Treigyte,G., Magnusson,K.E. and Navakauskiene,R. (2006) The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines. Eur. J. Pharmacol., 549, 9-18. (Pubitemid 44441256)
41. Chan,J.K., Sun,L., Yang,X.J., Zhu,G. and Wu,Z. (2003) Functional characterization of an amino-terminal region of HDAC4 that possesses MEF2 binding and transcriptional repressive activity. J. Biol. Chem., 278, 23515-23521. (Pubitemid 36830170)
42. Otwinowski,Z. and Minor,W. (1997) Processing of x-ray diffraction data collected in oscillation mode. Meth. Enzymol., 276, 307-326. (Pubitemid 27085611)
43. Adams,P.D., Afonine,P.V., Bunkoczi,G., Chen,V.B., Davis,I.W., Echols,N., Headd,J.J., Hung,L.W., Kapral,G.J., Grosse-Kunstleve,R.W. et al. (2010) PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr., 66, 213-221.
44. Kleywegt,G. and Jones,T.A. (1994) In: Bailey,S., Hubbard,R. and Walker,D. (eds), From First Map to Final Map Model. Daresbury Laboratory, Warrington.
45. Lewis,T.L. Jr, Mao,T., Svoboda,K. and Arnold,D.B. (2009) Myosin-dependent targeting of transmembrane proteins to neuronal dendrites. Nat. Neurosci., 12, 568-576.